Clinical Significance: Carbamazepine Epoxide is the metabolite of Carbamazepine which is used in the treatment of epilepsy and neuropathic pain.
Tested in oral fluid only

Drug Class

Anticonvulsants

Metabolite(s)

None

Aliases

Metabolite of Carbamazepine

Methodology

Liquid Chromatography Mass Spectrometry

Urine Recommended Volume

30mL

Oral Fluid Minimum Volume

1mL

Specimen Stability

15 days

Urine Reportable Range

40-1000

Oral Fluid Reportable Range

12-300

Urine Immunoassay Cutoff (ng/mL)

N/A

Urine Window of Detection

N/A

Oral Fluid Window of Detection

2-3 days

Rejection Criteria

Quantity Not Sufficient or Wrong Collection Device (Oral Fluid)

Urine Transient Contanier

Urine Clinical Drug Test Transport Cup

Oral Fluid Transient Contanier

Oral Fluid Intercept 2.0 Devices